Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence
Authors' conclusion
When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
Study context
- Population
- Patients with papillary thyroid microcarcinoma (PTMC) who underwent surgical treatment at Chungnam National University Hospital
- Participants
- 2,717 patients
- Exposure
- Recurrence vs no recurrence after surgery for PTMC
- Recurrencen = 60
- Outcome
- Preoperatively identifiable clinical factors related to recurrence
Methodological detailssingle-centre
- Single-centre
Main finding
As reported in the abstract
- BRAF mutation and tall cell variant significantly more common in patients with recurrence
- Age ≥55 years: lower risk of recurrence than younger patients and higher recurrence-free survival rate
Observational data: associations, not effects.
Original publication
Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence. Eur Thyroid J. Published 28 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →